Celcuity Inc. (NASDAQ:CELC) Receives Average Rating of “Buy” from Brokerages

Celcuity Inc. (NASDAQ:CELC) has earned an average rating of “Buy” from the seven research firms that are covering the stock, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $30.17.

CELC has been the topic of several analyst reports. HC Wainwright reaffirmed a “buy” rating and set a $27.00 price target on shares of Celcuity in a report on Friday, November 15th. Needham & Company LLC upped their target price on shares of Celcuity from $23.00 to $29.00 and gave the stock a “buy” rating in a report on Thursday, February 6th.

Institutional Trading of Celcuity

Several hedge funds have recently bought and sold shares of the stock. BNP Paribas Financial Markets grew its position in shares of Celcuity by 2,083.4% during the third quarter. BNP Paribas Financial Markets now owns 45,110 shares of the company’s stock valued at $673,000 after purchasing an additional 43,044 shares in the last quarter. Geode Capital Management LLC grew its holdings in Celcuity by 27.6% during the 3rd quarter. Geode Capital Management LLC now owns 630,369 shares of the company’s stock valued at $9,401,000 after buying an additional 136,518 shares in the last quarter. State Street Corp increased its stake in Celcuity by 152.2% in the 3rd quarter. State Street Corp now owns 1,107,415 shares of the company’s stock worth $16,512,000 after acquiring an additional 668,318 shares during the last quarter. Braidwell LP raised its holdings in shares of Celcuity by 71.2% during the 3rd quarter. Braidwell LP now owns 884,306 shares of the company’s stock worth $13,185,000 after acquiring an additional 367,663 shares in the last quarter. Finally, Barclays PLC raised its holdings in shares of Celcuity by 567.6% during the 3rd quarter. Barclays PLC now owns 53,605 shares of the company’s stock worth $800,000 after acquiring an additional 45,576 shares in the last quarter. Hedge funds and other institutional investors own 63.33% of the company’s stock.

Celcuity Stock Up 2.1 %

NASDAQ CELC opened at $12.88 on Friday. Celcuity has a 52 week low of $10.35 and a 52 week high of $22.19. The company has a quick ratio of 10.36, a current ratio of 10.35 and a debt-to-equity ratio of 0.65. The company has a market capitalization of $478.23 million, a P/E ratio of -4.93 and a beta of 0.73. The stock’s 50-day moving average price is $12.26 and its 200-day moving average price is $14.19.

About Celcuity

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.